Ânima (ANIM3) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
8 Jul, 2026Executive summary
Consolidated net revenue grew 2.9% in 2Q25 and 4.0% in 1H25 year-over-year, with all business segments contributing positively.
Adjusted EBITDA ex-IFRS16 increased 4.6% in 2Q25 and 7.7% in 1H25, supporting net income growth and margin expansion.
Adjusted net income attributable to controlling shareholders rose 18.9% in 2Q25 and 11.8% in 1H25 year-over-year.
Operating cash flow reached R$352.0 million in 2Q25 (+10.6% YoY) and R$778.1 million in 1H25 (+7.0% YoY), with leverage reduced to 2.66x net debt/EBITDA ex-IFRS16 LTM.
Strategic investments included the launch of the Community Creators Academy, acquisitions in medical education, and increased CAPEX focused on innovation and growth.
Financial highlights
Net revenue: R$1,005.3 million in 2Q25 (+2.9% YoY); R$2,045.5 million in 1H25 (+4.0% YoY).
Adjusted EBITDA ex-IFRS16: R$281.3 million in 2Q25 (+4.6% YoY); R$641.9 million in 1H25 (+7.7% YoY).
Adjusted net income: R$29.2 million in 2Q25 (+18.9% YoY); R$144.5 million in 1H25 (+11.8% YoY).
Operating cash flow: R$352.0 million in 2Q25 (+10.6% YoY); R$778.1 million in 1H25 (+7.0% YoY).
Adjusted EBITDA margin ex-IFRS16: 28.0% in 2Q25 (+0.5pp YoY); 31.4% in 1H25 (+1.1pp YoY).
Outlook and guidance
Management remains focused on sustainable revenue growth, operational efficiency, and quality, with optimism regarding regulatory changes in Distance Learning.
Strategic positioning in hybrid and face-to-face education expected to benefit from new regulations, especially in Health and Engineering.
Ongoing investments in innovation, including the launch of Community Creators Academy.
Latest events from Ânima
- Revenue and profitability rose across all segments, with improved leverage and cash flow.ANIM3
Q1 20258 Jul 2026 - Net revenue rose 5.8% to R$4.02B, with 11.2% EBITDA growth and 45.3% higher net income.ANIM3
Q4 20258 Jul 2026 - Revenue, EBITDA, and net income rose sharply in 3Q25, with leverage down to 2.40x.ANIM3
Q3 20258 Jul 2026 - Margin and profit growth, lower leverage, and strong digital and medical segment performance.ANIM3
Q2 20248 Jul 2026 - Net revenue up 7.7% and net income up 11.0%, with improved leverage and strong cash flow.ANIM3
Q1 20268 Jul 2026 - EBITDA ex-IFRS16 up 17.5% to R$1.08B, net income R$187M, leverage down to 2.8x.ANIM3
Q4 20246 Jul 2026 - Record margin expansion and cash generation drive lower leverage and improved profitability.ANIM3
Q3 20246 Jul 2026 - AI-driven expansion and disciplined growth are transforming education quality and impact.ANIM3
Investor Day 20253 Feb 2026 - New CEO appointed to drive growth, efficiency, and ESG focus after structured succession.ANIM3
Status Update3 Feb 2026